Correlation Between Tarsus Pharmaceuticals and Anheuser Busch

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Anheuser Busch at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Anheuser Busch into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Anheuser Busch Inbev, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Anheuser Busch and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Anheuser Busch. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Anheuser Busch.

Diversification Opportunities for Tarsus Pharmaceuticals and Anheuser Busch

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Tarsus and Anheuser is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Anheuser Busch Inbev in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anheuser Busch Inbev and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Anheuser Busch. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anheuser Busch Inbev has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Anheuser Busch go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Anheuser Busch

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 2.91 times more return on investment than Anheuser Busch. However, Tarsus Pharmaceuticals is 2.91 times more volatile than Anheuser Busch Inbev. It trades about 0.12 of its potential returns per unit of risk. Anheuser Busch Inbev is currently generating about -0.09 per unit of risk. If you would invest  3,263  in Tarsus Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  1,982  from holding Tarsus Pharmaceuticals or generate 60.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  Anheuser Busch Inbev

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

26 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Anheuser Busch Inbev 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anheuser Busch Inbev has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Tarsus Pharmaceuticals and Anheuser Busch Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and Anheuser Busch

The main advantage of trading using opposite Tarsus Pharmaceuticals and Anheuser Busch positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Anheuser Busch can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anheuser Busch will offset losses from the drop in Anheuser Busch's long position.
The idea behind Tarsus Pharmaceuticals and Anheuser Busch Inbev pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon